Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service
- PMID: 28682218
- DOI: 10.1080/02791072.2017.1342151
Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service
Abstract
Cocaine continues to be a worldwide public health concern in Europe. To improve prognosis and intervention, it is necessary to understand the characteristics of the patients who depend on the services where they receive care. The objective is to analyze the differences among patients who use cocaine and between ambulatory and residential resources to better adapt treatment. This is a descriptive, observational study of two populations of cocaine users in treatment: the ambulatory therapeutic community (ATC) and the therapeutic community (TC). The PRISM diagnostic interview was used for both groups. An analysis of both populations indicates a high prevalence of cocaine, heroin, cannabis, sedative, psychostimulant, and hallucinogen use disorders in the TC population compared to the ATC. In alcohol use disorder, differences between both mental health services were not observed. The degree of severity of cocaine use disorders (CUD) is greater in the TC population. The prevalence of psychiatric comorbidity is not statistically significant between the two populations, except for primary psychotic disorders, which are more prevalent in the TC population. This difference in the prevalence of psychotic disorders may be related to the high prevalence of cannabis use disorders in TC patients. Differences in the prevalence of substance use disorders, severity of CUD, and psychiatric comorbidity may limit the efficiency of mental health services involved in substance use disorder therapeutics. These results suggest the need for careful and extensive phenotyping of patients to improve intervention and prognosis in a clinical resource-dependent manner.
Keywords: Ambulatory treatment centers; cocaine use disorder; psychiatric comorbidity; substance use disorder; therapeutic communities.
Similar articles
-
Psychiatric comorbidity in cocaine users treated in therapeutic community: substance-induced versus independent disorders.Psychiatry Res. 2012 Dec 30;200(2-3):734-41. doi: 10.1016/j.psychres.2012.07.043. Epub 2012 Aug 19. Psychiatry Res. 2012. PMID: 22910475
-
[Psychopathological comorbidity in cocaine users in outpatient treatment].Adicciones. 2014;26(1):15-26. Adicciones. 2014. PMID: 24652395 Spanish.
-
Psychiatric comorbidity in a sample of cocaine-dependent outpatients seen in the Community of Madrid drug addiction care network.Adicciones. 2016 Mar 2;28(1):6-18. doi: 10.20882/adicciones.785. Adicciones. 2016. PMID: 26990385 English, Spanish.
-
Diagnosis and consequences of cocaine addiction.Curr Med Chem. 2012;19(33):5612-8. doi: 10.2174/092986712803988839. Curr Med Chem. 2012. PMID: 22856661 Review.
-
[Cocaine induced psychotic disorders: a review].Rev Med Liege. 2010 Nov;65(11):623-7. Rev Med Liege. 2010. PMID: 21189528 Review. French.
Cited by
-
Abstinence duration and psychopathology among addiction outpatients during 18 months of COVID-19.Front Psychiatry. 2024 Feb 8;15:1339730. doi: 10.3389/fpsyt.2024.1339730. eCollection 2024. Front Psychiatry. 2024. PMID: 38389986 Free PMC article.
-
Tryptophan and Substance Abuse: Mechanisms and Impact.Int J Mol Sci. 2023 Feb 1;24(3):2737. doi: 10.3390/ijms24032737. Int J Mol Sci. 2023. PMID: 36769059 Free PMC article. Review.
-
Effects of a Residential Multimodal Psychological Treatment in an Addicted Population, at 6 and 12 Months: Differences Between Men and Women.Front Psychiatry. 2022 Jun 16;13:862858. doi: 10.3389/fpsyt.2022.862858. eCollection 2022. Front Psychiatry. 2022. PMID: 35782433 Free PMC article.
-
Influence of gender and education on cocaine users in an outpatient cohort in Spain.Sci Rep. 2021 Oct 22;11(1):20928. doi: 10.1038/s41598-021-00472-7. Sci Rep. 2021. PMID: 34686732 Free PMC article.
-
Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management.Therap Adv Gastroenterol. 2021 Aug 27;14:17562848211016563. doi: 10.1177/17562848211016563. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 34471422 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials